Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-038043
Filing Date
2021-06-03
Accepted
2021-06-03 20:55:40
Documents
1
Period of Report
2021-03-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14055
  Complete submission text file 0001209191-21-038043.txt   15427
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
NELSEN ROBERT (Reporting) CIK: 0001219042 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38311 | Film No.: 21994548

Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Issuer) CIK: 0001714899 (see all company filings)

EIN.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)